ArticleFrontiers in pediatrics2025
Stratified dynamic analysis reveals postoperative recovery trajectories of sacral neuromodulation in pediatric neurogenic bladder.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the effectiveness and safety of sacral neuromodulation (SNM) under general anaesthesia in the treatment of neurogenic bladder (NB) in children, and to share clinical experience. Methods: We conducted a retrospective analysis of the clinical data of 61 children with neurogenic bladder (NB) who successfully underwent sacral neuromodulation (SNM) treatment at Qilu Hospital of Shandong University from January 2021 to January 2025, with mid-term follow-up (up to 3 years). By tracking key indicators (such as symptomatology and urodynamic parameters) over an extended period, we assessed the safety and efficacy of SNM under general anesthesia for the treatment of pediatric NB and identified general patterns of postoperative recovery. Results: Preoperatively, all 61 children exhibited symptoms of urinary frequency, urgency, and incontinence. After permanent SNM implantation, compared to baseline, symptoms of voiding dysfunction, including urinary frequency, incontinence, and urinary retention, were significantly alleviated. Urodynamic parameters, including detrusor pressure during the storage phase, bladder compliance, and maximum bladder capacity, also showed statistically significant improvements ( Conclusion: Sacral neuromodulation (SNM) under general anesthesia is a safe and reliable treatment for pediatric patients. Both early and mid-term postoperative care play a crucial role in optimizing recovery and ensuring sustained therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.